Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor.

Jiayu Ling,Lishuo Shi,Xingyu Cheng,Yang Fu, Ziqin Lin,Yandong Zhao, Zheqing Li,Jianwei Zhang,Huabin Hu,Yue Cai,Yanhong Deng

Journal of gastrointestinal oncology（2023）

引用 0|浏览10

暂无评分

摘要

When compared to UR + AT, NAT + resection + AT may reduce the risk of distant recurrence in localized GIST and may be especially beneficial for patients with non-gastric GISTs.

查看译文

关键词

Gastrointestinal stromal tumors,imatinib mesylate,neoadjuvant therapy,retrospective studies,treatment outcome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要